DK1399141T3 - Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte - Google Patents
Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerteInfo
- Publication number
- DK1399141T3 DK1399141T3 DK02728055T DK02728055T DK1399141T3 DK 1399141 T3 DK1399141 T3 DK 1399141T3 DK 02728055 T DK02728055 T DK 02728055T DK 02728055 T DK02728055 T DK 02728055T DK 1399141 T3 DK1399141 T3 DK 1399141T3
- Authority
- DK
- Denmark
- Prior art keywords
- carnitine
- acetyl
- medicament
- prevention
- post
- Prior art date
Links
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 208000004550 Postoperative Pain Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000009117 preventive therapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000293A ITRM20010293A1 (it) | 2001-05-29 | 2001-05-29 | Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. |
| PCT/IT2002/000336 WO2002096409A1 (en) | 2001-05-29 | 2002-05-24 | Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1399141T3 true DK1399141T3 (da) | 2008-01-02 |
Family
ID=11455557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02728055T DK1399141T3 (da) | 2001-05-29 | 2002-05-24 | Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20040152781A1 (enExample) |
| EP (1) | EP1399141B1 (enExample) |
| JP (1) | JP4287660B2 (enExample) |
| KR (1) | KR100873748B1 (enExample) |
| AT (1) | ATE374021T1 (enExample) |
| CA (1) | CA2448242C (enExample) |
| CY (1) | CY1107037T1 (enExample) |
| CZ (1) | CZ20033220A3 (enExample) |
| DE (1) | DE60222662T2 (enExample) |
| DK (1) | DK1399141T3 (enExample) |
| ES (1) | ES2290292T3 (enExample) |
| HU (1) | HUP0401294A3 (enExample) |
| IT (1) | ITRM20010293A1 (enExample) |
| MX (1) | MXPA03010919A (enExample) |
| PL (1) | PL367616A1 (enExample) |
| PT (1) | PT1399141E (enExample) |
| SK (1) | SK287559B6 (enExample) |
| WO (1) | WO2002096409A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040606A1 (it) | 2004-12-13 | 2005-03-13 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica. |
| JP5685362B2 (ja) * | 2005-04-26 | 2015-03-18 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ | 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン |
| IT202200022437A1 (it) | 2022-11-02 | 2024-05-02 | Chiesi Italia S P A | Composizione farmaceutica comprendente l-acetilcarnitina e beta-cariofillene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
| IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
| IT1277147B1 (it) * | 1995-01-20 | 1997-11-04 | Sigma Tau Ind Farmaceuti | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
-
2001
- 2001-05-29 IT IT2001RM000293A patent/ITRM20010293A1/it unknown
-
2002
- 2002-05-24 US US10/478,379 patent/US20040152781A1/en not_active Abandoned
- 2002-05-24 ES ES02728055T patent/ES2290292T3/es not_active Expired - Lifetime
- 2002-05-24 KR KR1020037015574A patent/KR100873748B1/ko not_active Expired - Fee Related
- 2002-05-24 DK DK02728055T patent/DK1399141T3/da active
- 2002-05-24 WO PCT/IT2002/000336 patent/WO2002096409A1/en not_active Ceased
- 2002-05-24 SK SK1584-2003A patent/SK287559B6/sk not_active IP Right Cessation
- 2002-05-24 DE DE60222662T patent/DE60222662T2/de not_active Expired - Lifetime
- 2002-05-24 AT AT02728055T patent/ATE374021T1/de not_active IP Right Cessation
- 2002-05-24 PL PL02367616A patent/PL367616A1/xx not_active IP Right Cessation
- 2002-05-24 CZ CZ20033220A patent/CZ20033220A3/cs unknown
- 2002-05-24 MX MXPA03010919A patent/MXPA03010919A/es active IP Right Grant
- 2002-05-24 EP EP02728055A patent/EP1399141B1/en not_active Expired - Lifetime
- 2002-05-24 HU HU0401294A patent/HUP0401294A3/hu unknown
- 2002-05-24 JP JP2002592919A patent/JP4287660B2/ja not_active Expired - Fee Related
- 2002-05-24 CA CA2448242A patent/CA2448242C/en not_active Expired - Fee Related
- 2002-05-24 PT PT02728055T patent/PT1399141E/pt unknown
-
2007
- 2007-11-28 CY CY20071101520T patent/CY1107037T1/el unknown
-
2008
- 2008-09-26 US US12/232,945 patent/US20090062388A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090062388A1 (en) | 2009-03-05 |
| KR100873748B1 (ko) | 2008-12-12 |
| JP2004532865A (ja) | 2004-10-28 |
| CA2448242C (en) | 2011-01-11 |
| SK287559B6 (sk) | 2011-02-04 |
| JP4287660B2 (ja) | 2009-07-01 |
| WO2002096409A1 (en) | 2002-12-05 |
| SK15842003A3 (sk) | 2004-06-08 |
| KR20040003030A (ko) | 2004-01-07 |
| CY1107037T1 (el) | 2012-09-26 |
| EP1399141B1 (en) | 2007-09-26 |
| ATE374021T1 (de) | 2007-10-15 |
| ITRM20010293A0 (it) | 2001-05-29 |
| CA2448242A1 (en) | 2002-12-05 |
| PT1399141E (pt) | 2007-11-16 |
| US20040152781A1 (en) | 2004-08-05 |
| ITRM20010293A1 (it) | 2002-11-29 |
| ES2290292T3 (es) | 2008-02-16 |
| HUP0401294A3 (en) | 2008-04-28 |
| DE60222662D1 (de) | 2007-11-08 |
| CZ20033220A3 (en) | 2004-06-16 |
| EP1399141A1 (en) | 2004-03-24 |
| PL367616A1 (en) | 2005-03-07 |
| MXPA03010919A (es) | 2004-02-27 |
| DE60222662T2 (de) | 2008-06-26 |
| HUP0401294A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY127290A (en) | New use of flibanserin | |
| MXPA03007712A (es) | Sales farmaceuticas. | |
| IL205262A (en) | Use of Risderdone Acid or its Pharmaceutical Salt to produce oral medication once a month for the prevention and treatment of osteoporosis | |
| BR0015188A (pt) | Composições farmacêuticas | |
| PT1441705E (pt) | Sistemas terapêuticos sólidos, estabilizados, de libertação rápida e/ou modificada para a administração oral de princípios ativos, excipientes ou produtos alimentares líquidos | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| DE50203456D1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| BR0211063A (pt) | Sais de derivados anticonvulsivantes | |
| WO2005004915A3 (en) | Compositions comprising meloxicam | |
| DK1150704T3 (da) | Melagatran til behandling af betændelse | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| CY1107037T1 (el) | Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου | |
| CA2493885A1 (en) | Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistically analgesic effect in mammals | |
| DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
| DK1490049T3 (da) | Citalopram til behandling af forhöjet blodtryk | |
| WO2005060978A3 (en) | Polymetaphosphate based formulations for therapy of microcrystalline arthropathies | |
| TNSN99158A1 (ar) | طريقة لمنع الاصابة بالربو | |
| WO2002047689A3 (en) | Use of cetirizine or efletirizine for preventing urticaria | |
| UA87292C2 (ru) | Применение сирамезина для лечения злокачественных опухолей | |
| WO2004035031A3 (en) | Treatment of uveal melanoma | |
| DK1817029T3 (da) | Isoxazolderivat til lindring af neuropatiske smerter | |
| PL1838392T3 (pl) | Leki zawierające selen na śródbłonkowe choroby układu naczyniowego |